Maximize your thought leadership

AAA Biotech Expands Recombinant Proteins Portfolio to Advance Life Sciences Research

By FisherVista

TL;DR

AAA Biotech's expansion of recombinant proteins offers researchers a competitive edge by providing high-quality, versatile tools for groundbreaking biomedical research.

AAA Biotech delivers recombinant proteins with over 95% purity, utilizing various expression systems and rigorous QC to ensure reliability for scientific experiments.

By supplying high-quality recombinant proteins, AAA Biotech accelerates life sciences research, paving the way for medical breakthroughs that improve global health.

Discover how AAA Biotech's recombinant proteins, with their high purity and flexibility, are revolutionizing experiments in life sciences today.

Found this article helpful?

Share it with your network and spread the knowledge!

AAA Biotech Expands Recombinant Proteins Portfolio to Advance Life Sciences Research

AAA Biotech has announced significant additions to its recombinant proteins (rProteins) portfolio, reinforcing its position as a global leader in high-quality research reagents. This expansion is set to provide researchers with an even broader range of tools for biomedical research, catering to the diverse needs of experiments in life sciences.

Recombinant proteins are pivotal in modern life sciences research, serving as essential tools for studying protein-protein and protein-DNA interactions, among other applications. AAA Biotech's rProteins are produced through specific, controlled genetic engineering methods, ensuring high purity and activity. The company guarantees that the majority of its proteins are over 95% pure, with bioactivity forms rigorously tested to meet the stringent demands of scientific research.

The versatility of AAA Biotech's rProteins is one of their standout features. They can be expressed in various systems, including prokaryotic (E. coli) and eukaryotic (HEK293, CHO, yeast, insect) systems, to accommodate different research needs related to folding, post-translational modification, and functionality. This flexibility makes them ideal for a wide range of applications, from drug discovery to the validation of biomarkers and analysis of immune signaling.

Moreover, AAA Biotech offers custom variants of rProteins, allowing researchers to tailor expressions and tags to their specific experimental requirements. Each product undergoes tight quality control and documentation, including testing by SDS-PAGE, endotoxin levels, and, where applicable, activity assays. Certificates of Analysis are provided on a per-batch basis, ensuring researchers have access to detailed information about the products they use.

The rProteins are available in user-friendly formats, such as lyophilized or ready-to-use liquid forms, facilitating easy storage and handling. This attention to detail underscores AAA Biotech's commitment to supporting the scientific community with reliable, high-quality research reagents.

For more information on AAA Biotech's comprehensive range of research reagents, including their expanded rProteins portfolio, visit their official website at https://www.aaabiotech.com/.

Curated from 24-7 Press Release

blockchain registration record for this content
FisherVista

FisherVista

@fishervista